US · Healthcare

Imagion Biosystems Limited (IBXXF)

Diagnostics & Research

Imagion Biosystems Limited (IBXXF) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IBXXF

P/E ratio

18.00

Imagion Biosystems Limited (IBXXF) — FAQ

What is IBXXF's P/E ratio?

The price-to-earnings (P/E) ratio for Imagion Biosystems Limited (IBXXF) is 18.00 (data as of 2026-03-24).

Does Imagion Biosystems Limited pay a dividend?

Dividend yield is not available in the current snapshot for Imagion Biosystems Limited (IBXXF). Check the MyAverix Finance app for the latest dividend data.

What sector is Imagion Biosystems Limited in?

Imagion Biosystems Limited (IBXXF) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is IBXXF listed on?

IBXXF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)